MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2016 International Congress

    Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

    K.L. Andrzejewski, A. Owens, M.T. Bull, K.M. Biglan, S. Kanchana, J.W. Mink, R. Barbano (Rochester, NY, USA)

    Objective: To determine if individuals with cervical dystonia have altered vestibular function compared to unaffected individuals, and whether botulinum toxin treatment alters those variables. Background:…
  • 2016 International Congress

    Acute movement disorders in Tunisian childhood

    H. Benrhouma, H. Klaa, A. Nasri, I. Kraoua, I. Turki (Tunis, Tunisia)

    Objective: To describe clinical, imaging and therapeutic features in 80 children with acute movement disorders. Background: Acute movement disorders are usually misdiagnosed in childhood. Our…
  • 2016 International Congress

    Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest

    L. Klingelhoefer, M. Kaiser, D. Martino, L. Perkins, M. Wienecke, A. Sauerbier, R. Untucht, D. Trivedi, K. Mammadova, T. Chiwera, A. Rizos, P. Martinez-Martin, H. Reichmann, K.R. Chaudhuri (Dresden, Germany)

    Objective: To validate a non motor symptom (NMS) questionnaire in patients with craniocervical dystonia (CCD). Background: We have reported the clinical use of a Dystonia…
  • 2016 International Congress

    Digitally captured Archimedes spiral indices correlate with clinical assessment of dystonia severity

    J.B. Ratliff, A. Mirallave, R. Ortega, A. Glickman, Q. Yu, D. Raymond, S. Bressman, S. Pullman, R. Saunders-Pullman (New York, NY, USA)

    Objective: To determine whether digitized spiral analysis captures severity of dystonia in comparison to motor scores from the clinical gold standard, the Burke-Fahn-Marsden rating scale…
  • 2016 International Congress

    Chewing-induced blepharospasm in Parkinson’s disease

    E. Sasse, L.F. Vasconcellos, M. Spitz (Rio de Janeiro, Brazil)

    Objective: Report and discuss a rare presentation of BS. Background: Dystonia is described in untreated Parkinson's disease (PD) patients and is also one of the…
  • 2016 International Congress

    Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

    B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

    Objective: To present a rare case of adult onset NPC patient and pointing out varying response of her distinct symptoms on long term follow up…
  • 2016 International Congress

    Development of a tool for assessment of embarrassment due to dystonia

    R. Verma, K.S. Anand (New Delhi, India)

    Objective: To develop a self assessment scale for quantitative measurement of embarrassment in patients having dystonia. Background: Patients suffering from movement abnormalities like dystonia frequently…
  • 2016 International Congress

    Seated balance is impaired in patients with idiopathic cervical dystonia

    J. De Pauw, R. Mercelis, A. Hallemans, G. Van Gils, S. Truijen, P. Cras, W. De Hertogh (Antwerp, Belgium)

    Objective: To investigate whether seated balance is impaired in patients with idiopathic Cervical Dystonia (CD). Background: Idiopathic CD is a movement disorder in which involuntary…
  • 2016 International Congress

    Combined pallidal and thalamic stimulation for multifocal primary dystonia with prominent writers’ cramp

    A. Wloch, M. Abdallat, G. Lütjens, C. Schrader, J.K. Krauss (Hannover, Germany)

    Objective: When a patient presents with both writer's cramp and other dystonic symptoms, it is unclear which target should be chosen. Multifocal DBS is a…
  • 2016 International Congress

    A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

    R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)

    Objective: To assess the safety, tolerability, and pharmacokinetics of single oral doses of RE-024 in healthy adult volunteers. Background: PKAN is a rare, autosomal recessive,…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley